Mifepristone and Oral Misoprostol for Early Medical Abortion

Authors

  • V Shrivastava Department of Obstretics and Gynecology, Nepal Medical College Teaching Hospital, Jorpati, Nepal
  • A Shrivastava Kathmandu

Keywords:

medical abortion, misoprostol, mifepristone

Abstract

Background: Combined mifepristone and misoprostol is the best method of medical termination of pregnancy. The study is undertaken to find out the success rate, acceptability, efficacy and patient satisfaction of medical abortion in pregnant women with 49 days of gestation.

Methods: The pregnant women with amenorrhea of 49 days or less seeking termination of pregnancy received were studied. The 200 mg of oral mifepristone and followed 48 hours later with 600 microgram of oral misoprostol were given.

Results: The success rate with the regime was 47 (94%) and 49 (98%) were satisfied. Weakness 24 (48%), Nausea 10 (20%), diarrhea 12 (25%), needing analgesic 4 (8%) were the side effects of the combined regime.

Conclusions: Medical termination of pregnancy with combination of mifepristone and oral misoprostol has a good success rate. The side effect of the regimen in our setup is less and well accepted. Majority of the patient are satisfied with medical termination of pregnancy.

Key words: medical abortion; misoprostol; mifepristone

DOI: 10.3126/jnhrc.v7i2.3021

Journal of Nepal Health Research Council Vol.7(2) Apr 2009 127-130

Downloads

Download data is not yet available.
Abstract
40099
PDF
1120

Downloads

How to Cite

Shrivastava, V., & Shrivastava, A. (2010). Mifepristone and Oral Misoprostol for Early Medical Abortion. Journal of Nepal Health Research Council, 7(2), 127–130. Retrieved from https://nepjol.info./index.php/JNHRC/article/view/3021

Issue

Vol. 7 No. 2 (2009)

Section

Original Articles

License

Submission of the manuscript means that the authors agree to assign exclusive copyright to JNHRC. The aim of JNHRC is to increase the visibility and ease of use of open access scientific and scholarly articles thereby promoting their increased usage and impact. Hence, JNHRC grants permission to read, download, copy, distribute, print, search, or link to the full texts of these articles which is available online (http://jnhrc.com.np) freely.

Creative Commons License
The articles in this journal are licensed under a Creative Commons Attribution 4.0 International License.